15 participants
Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-08-24
- Start Date:
- 2021-09-30
- Completion:
- 2022-06-30
Conditions
- Cervical Squamous Cell Carcinoma
Interventions
- DRUG
No Results Yet